Resources

Supported by a seed grant from the World Bank, PATH began to focus on cervical cancer in 1991. Since then, our portfolio has expanded tremendously, thanks in large part to grants from the Bill & Melinda Gates Foundation. In this report, we describe our key cervical cancer prevention initiatives.

This brief describes two human papillomavirus (HPV) screening methods developed and tested by PATH for low-resource settings: the careHPV™ DNA test and the OncoE6™ cervical test.

This operational assessment of Sayana® Press in Senegal examines the extent to which Sayana® Press facilitates the logistics of managing and administering injectable contraception and assesses whether providers in Senegal find benefits in this new presentation.

Since 2009, PATH has been working with government family planning officials to engage stakeholders and apply evidence to develop a total market plan for family planning in light of funding shortfalls. This case study in Nicaragua is intended to highlight lessons learned and recommendations for those considering similar initiatives in other settings. It is a sister document to the Vietnam case study, Developing a Total Market Plan for Family Planning in Vietnam.

To support a total market approach to family planning in Nicaragua, PATH is helping to enhance the equity and accessibility of family planning services. This study in Nicaragua segments public- and private-sector users into different subgroups, each with its own profile, and makes recommendations about how best to meet the needs of each group. The document highlights not only demographic and economic variations but also differences in values and attitudes, all of which are key drivers of family planning demand.